{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:00:27Z","timestamp":1778857227190,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007362","name":"Abisch-Frenkel-Stiftung","doi-asserted-by":"publisher","award":["15\/H1"],"award-info":[{"award-number":["15\/H1"]}],"id":[{"id":"10.13039\/501100007362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2015PG-ISL007"],"award-info":[{"award-number":["2015PG-ISL007"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1882\/16"],"award-info":[{"award-number":["1882\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes mellitus (DM) significantly increases susceptibility to central nervous system (CNS) pathologies, including stroke, vascular dementia, cognitive deficits and Alzheimer\u2019s disease. Previous studies (mostly using the streptozotocin model) suggested that blood-brain barrier (BBB) disruption is involved in these conditions. Here, we examined the integrity of brain capillaries and BBB permeability in Lepr<jats:sup>db\/db<\/jats:sup> obesity-related diabetic mice. Surprisingly, significant BBB leakage was observed only in young mice at the pre-hyperglycemic stage. Thorough examination of barrier permeability at later diabetic stages showed no evidence for significant BBB leakage during the hyperglycemic state. Electron microscopy imaging of mice with short-term hyperglycaemia supported normal BBB permeability but indicated other stress-related changes in capillary ultrastructure, such as mitochondrial degeneration. Based on our study with this mouse genetic model of obesity-related DM, we suggest that previously reported hyperglycaemia-induced BBB leakage is most likely not the underlying mechanism of DM-related CNS pathologies. Finally we propose that BBB hyper-permeability might be an early and transient phenomenon while stress-related endothelial pathologies do correlate with a short-term diabetic state.<\/jats:p>","DOI":"10.1038\/s41598-019-39230-1","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:27:43Z","timestamp":1551266863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Leptin receptor deficiency induces early, transient and hyperglycaemia-independent blood-brain barrier dysfunction"],"prefix":"10.1038","volume":"9","author":[{"given":"Noa","family":"Corem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Anzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivan","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayal","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"39230_CR1","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/diacare.27.10.2540","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong, D. S., Aiello, L. P., Ferris, F. L. III. & Klein, R. Diabetic retinopathy. Diabetes Care 27, 2540\u20132553 (2004).","journal-title":"Diabetes Care"},{"key":"39230_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross, J. L. et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28, 164\u2013176 (2005).","journal-title":"Diabetes Care"},{"key":"39230_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1523-1755.2001.00789.x","volume":"60","author":"N Chaturvedi","year":"2001","unstructured":"Chaturvedi, N. et al. Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60, 219\u2013227, https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00789.x (2001).","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"39230_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2337\/dc07-S004","volume":"30","author":"A American Diabetes","year":"2007","unstructured":"American Diabetes, A. Standards of medical care in diabetes\u20132007. Diabetes Care 30(Suppl 1), S4\u2013S41, https:\/\/doi.org\/10.2337\/dc07-S004 (2007).","journal-title":"Diabetes Care"},{"key":"39230_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton, A. J. et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956\u2013962 (2005).","journal-title":"Diabetes Care"},{"key":"39230_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.2174\/138161208784705441","volume":"14","author":"JD Huber","year":"2008","unstructured":"Huber, J. D. Diabetes, cognitive function, and the blood-brain barrier. Curr Pharm Des 14, 1594\u20131600 (2008).","journal-title":"Curr Pharm Des"},{"key":"39230_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2337\/diacare.24.2.366","volume":"24","author":"A Fontbonne","year":"2001","unstructured":"Fontbonne, A., Berr, C., Ducimetiere, P. & Alperovitch, A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24, 366\u2013370 (2001).","journal-title":"Diabetes Care"},{"key":"39230_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejphar.2004.02.054","volume":"490","author":"KV Allen","year":"2004","unstructured":"Allen, K. V., Frier, B. M. & Strachan, M. W. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490, 169\u2013175, https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.054 (2004).","journal-title":"Eur J Pharmacol"},{"key":"39230_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1212\/01.WNL.0000134666.64593.BA","volume":"63","author":"K Yaffe","year":"2004","unstructured":"Yaffe, K. et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658\u2013663 (2004).","journal-title":"Neurology"},{"key":"39230_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger, J. A. et al. Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570\u2013575, https:\/\/doi.org\/10.1001\/archneur.64.4.570 (2007).","journal-title":"Arch Neurol"},{"key":"39230_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3233\/JAD-2005-7108","volume":"7","author":"X Zhu","year":"2005","unstructured":"Zhu, X., Perry, G. & Smith, M. A. Insulin signaling, diabetes mellitus and risk of Alzheimer disease. J Alzheimers Dis 7, 81\u201384 (2005).","journal-title":"J Alzheimers Dis"},{"key":"39230_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178\u2013201, https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003 (2008).","journal-title":"Neuron"},{"key":"39230_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong, Z. et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11, 420\u2013422, https:\/\/doi.org\/10.1038\/nn2073 (2008).","journal-title":"Nat Neurosci"},{"key":"39230_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell, R. D. & Zlokovic, B. V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118, 103\u2013113, https:\/\/doi.org\/10.1007\/s00401-009-0522-3 (2009).","journal-title":"Acta Neuropathol"},{"key":"39230_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512\u2013516, https:\/\/doi.org\/10.1038\/nature11087 (2012).","journal-title":"Nature"},{"key":"39230_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr, J. M. et al. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74, 70\u201376 (2003).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"39230_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.semcdb.2014.12.006","volume":"38","author":"N Hagan","year":"2015","unstructured":"Hagan, N. & Ben-Zvi, A. The molecular, cellular, and morphological components of blood-brain barrier development during embryogenesis. Semin Cell Dev Biol 38, 7\u201315, https:\/\/doi.org\/10.1016\/j.semcdb.2014.12.006 (2015).","journal-title":"Semin Cell Dev Biol"},{"key":"39230_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0006-8993(94)90172-4","volume":"636","author":"WG Mayhan","year":"1994","unstructured":"Mayhan, W. G. Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res 636, 35\u201339 (1994).","journal-title":"Brain Res"},{"key":"39230_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00005072-198705000-00006","volume":"46","author":"E Rechthand","year":"1987","unstructured":"Rechthand, E., Smith, Q. R., Latker, C. H. & Rapoport, S. I. Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus. J Neuropathol Exp Neurol 46, 302\u2013314 (1987).","journal-title":"J Neuropathol Exp Neurol"},{"key":"39230_CR20","first-page":"1095","volume":"27","author":"SR Ennis","year":"1986","unstructured":"Ennis, S. R. & Betz, A. L. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. Invest Ophthalmol Vis Sci 27, 1095\u20131102 (1986).","journal-title":"Effects of diabetes, hypertonicity, and iodate. Invest Ophthalmol Vis Sci"},{"key":"39230_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","volume":"50","author":"BT Hawkins","year":"2007","unstructured":"Hawkins, B. T., Lundeen, T. F., Norwood, K. M., Brooks, H. L. & Egleton, R. D. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50, 202\u2013211, https:\/\/doi.org\/10.1007\/s00125-006-0485-z (2007).","journal-title":"Diabetologia"},{"key":"39230_CR22","doi-asserted-by":"publisher","first-page":"H2660","DOI":"10.1152\/ajpheart.00489.2006","volume":"291","author":"JD Huber","year":"2006","unstructured":"Huber, J. D., VanGilder, R. L. & Houser, K. A. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 291, H2660\u20132668, https:\/\/doi.org\/10.1152\/ajpheart.00489.2006 (2006).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"39230_CR23","doi-asserted-by":"publisher","first-page":"e24325","DOI":"10.1371\/journal.pone.0024325","volume":"6","author":"AL Dinel","year":"2011","unstructured":"Dinel, A. L. et al. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6, e24325, https:\/\/doi.org\/10.1371\/journal.pone.0024325 (2011).","journal-title":"PLoS One"},{"key":"39230_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0306-4522(02)00162-8","volume":"113","author":"XL Li","year":"2002","unstructured":"Li, X. L. et al. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113, 607\u2013615 (2002).","journal-title":"Neuroscience"},{"key":"39230_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.physbeh.2010.07.002","volume":"101","author":"AN Sharma","year":"2010","unstructured":"Sharma, A. N., Elased, K. M., Garrett, T. L. & Lucot, J. B. Neurobehavioral deficits in db\/db diabetic mice. Physiol Behav 101, 381\u2013388, https:\/\/doi.org\/10.1016\/j.physbeh.2010.07.002 (2010).","journal-title":"Physiol Behav"},{"key":"39230_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/0269881111434620","volume":"26","author":"AN Sharma","year":"2012","unstructured":"Sharma, A. N., Elased, K. M. & Lucot, J. B. Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db\/db diabetic mice. J Psychopharmacol 26, 724\u2013732, https:\/\/doi.org\/10.1177\/0269881111434620 (2012).","journal-title":"J Psychopharmacol"},{"key":"39230_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/dmrr.579","volume":"21","author":"YJ Liao","year":"2005","unstructured":"Liao, Y. J. et al. Oxidative damage in cerebral vessels of diabetic db\/db mice. Diabetes Metab Res Rev 21, 554\u2013559, https:\/\/doi.org\/10.1002\/dmrr.579 (2005).","journal-title":"Diabetes Metab Res Rev"},{"key":"39230_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bph.13378","volume":"173","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. PPARgamma agonists regulate bidirectional transport of amyloid-beta across the blood-brain barrier and hippocampus plasticity in db\/db mice. Br J Pharmacol 173, 372\u2013385, https:\/\/doi.org\/10.1111\/bph.13378 (2016).","journal-title":"Br J Pharmacol"},{"key":"39230_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jemt.22708","volume":"79","author":"R Fujihara","year":"2016","unstructured":"Fujihara, R. et al. Albumin microvascular leakage in brains with diabetes mellitus. Microsc Res Tech 79, 833\u2013837, https:\/\/doi.org\/10.1002\/jemt.22708 (2016).","journal-title":"Microsc Res Tech"},{"key":"39230_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jnc.12939","volume":"132","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal, A., Khera, A., Singh, I. & Sandhir, R. S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes. J Neurochem 132, 595\u2013608, https:\/\/doi.org\/10.1111\/jnc.12939 (2015).","journal-title":"J Neurochem"},{"key":"39230_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/db14-0759","volume":"64","author":"M Poittevin","year":"2015","unstructured":"Poittevin, M. et al. Diabetic microangiopathy: impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice. Diabetes 64, 999\u20131010, https:\/\/doi.org\/10.2337\/db14-0759 (2015).","journal-title":"Diabetes"},{"key":"39230_CR32","doi-asserted-by":"publisher","unstructured":"M\u00e4e, M. A. et al. Prolonged systemic hyperglycemia does not cause pericyte loss and permeability at the mouse blood-brain barrier. Sci Rep. 29;8(1):17462, https:\/\/doi.org\/10.1038\/s41598-018-35576-0 (2018).","DOI":"10.1038\/s41598-018-35576-0"},{"key":"39230_CR33","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1177\/0271678X16642233","volume":"36","author":"AM Stranahan","year":"2016","unstructured":"Stranahan, A. M., Hao, S., Dey, A., Yu, X. & Baban, B. Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice. J Cereb Blood Flow Metab 36, 2108\u20132121, https:\/\/doi.org\/10.1177\/0271678X16642233 (2016).","journal-title":"J Cereb Blood Flow Metab"},{"key":"39230_CR34","doi-asserted-by":"publisher","unstructured":"Rom, S. et al. Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models. Mol Neurobiol, https:\/\/doi.org\/10.1007\/s12035-018-1195-5 (2018).","DOI":"10.1007\/s12035-018-1195-5"},{"key":"39230_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0006-8993(90)90118-U","volume":"534","author":"WG Mayhan","year":"1990","unstructured":"Mayhan, W. G. Effect of diabetes mellitus on disruption of the blood-brain barrier during acute hypertension. Brain Res 534, 106\u2013110 (1990).","journal-title":"Brain Res"},{"key":"39230_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2337\/diab.30.6.500","volume":"30","author":"WT Stauber","year":"1981","unstructured":"Stauber, W. T., Ong, S. H. & McCuskey, R. S. Selective extravascular escape of albumin into the cerebral cortex of the diabetic rat. Diabetes 30, 500\u2013503 (1981).","journal-title":"Diabetes"},{"key":"39230_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/PCC.0b013e3181c013f4","volume":"11","author":"MS Vavilala","year":"2010","unstructured":"Vavilala, M. S. et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med 11, 332\u2013338, https:\/\/doi.org\/10.1097\/PCC.0b013e3181c013f4 (2010).","journal-title":"Pediatr Crit Care Med"},{"key":"39230_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1124\/jpet.116.237057","volume":"359","author":"TS Salameh","year":"2016","unstructured":"Salameh, T. S., Shah, G. N., Price, T. O., Hayden, M. R. & Banks, W. A. Blood-Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate. J Pharmacol Exp Ther 359, 452\u2013459, https:\/\/doi.org\/10.1124\/jpet.116.237057 (2016).","journal-title":"J Pharmacol Exp Ther"},{"key":"39230_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2337\/db16-0695","volume":"66","author":"H Qi","year":"2017","unstructured":"Qi, H. et al. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility. Diabetes 66, 763\u2013778, https:\/\/doi.org\/10.2337\/db16-0695 (2017).","journal-title":"Diabetes"},{"key":"39230_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cmet.2012.01.009","volume":"15","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 15, 186\u2013200, https:\/\/doi.org\/10.1016\/j.cmet.2012.01.009 (2012).","journal-title":"Cell Metab"},{"key":"39230_CR41","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1167\/iovs.16-21094","volume":"58","author":"BT Aldrich","year":"2017","unstructured":"Aldrich, B. T. et al. Mitochondrial and Morphologic Alterations in Native Human Corneal Endothelial Cells Associated With Diabetes Mellitus. Invest Ophthalmol Vis Sci 58, 2130\u20132138, https:\/\/doi.org\/10.1167\/iovs.16-21094 (2017).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"39230_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"NP Goncalves","year":"2017","unstructured":"Goncalves, N. P. et al. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol 13, 135\u2013147, https:\/\/doi.org\/10.1038\/nrneurol.2016.201 (2017).","journal-title":"Nat Rev Neurol"},{"key":"39230_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1479164114565629","volume":"12","author":"MS Joshi","year":"2015","unstructured":"Joshi, M. S. et al. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. Diab Vasc Dis Res 12, 208\u2013216, https:\/\/doi.org\/10.1177\/1479164114565629 (2015).","journal-title":"Diab Vasc Dis Res"},{"key":"39230_CR44","doi-asserted-by":"publisher","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","volume":"6","author":"E Zudaire","year":"2011","unstructured":"Zudaire, E., Gambardella, L., Kurcz, C. & Vermeren, S. A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385, https:\/\/doi.org\/10.1371\/journal.pone.0027385 (2011).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39230-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:28:33Z","timestamp":1671258513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39230-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2884"}}